Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John H Farley
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates Incorporated
Hinsdale, Illinois, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Maine Medical Center-Bramhall Campus
Portland, Maine, United States
- Christiana Care - Union Hospital
Elkton, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Bronson Battle Creek
Battle Creek, Michigan, United States
- Spectrum Health Big Rapids Hospital
Big Rapids, Michigan, United States
- Cancer Research Consortium of West Michigan Ncorp
Grand Rapids, Michigan, United States
- Mercy Health Saint Mary'S
Grand Rapids, Michigan, United States
- Spectrum Health at Butterworth Campus
Grand Rapids, Michigan, United States
- Holland Community Hospital
Holland, Michigan, United States
- Mercy Health Mercy Campus
Muskegon, Michigan, United States
- Mercy Health Partners-Hackley Campus
Muskegon, Michigan, United States
- Munson Medical Center
Traverse City, Michigan, United States
- Metro Health Hospital
Wyoming, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Cancer Research for the Ozarks Ncorp
Springfield, Missouri, United States
- Coxhealth South Hospital
Springfield, Missouri, United States
- Mercy Hospital Springfield
Springfield, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Cooper Hospital University Medical Center
Camden, New Jersey, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Novant Health Presbyterian Medical Center
Charlotte, North Carolina, United States
- Gynecologic Oncology Network
Greenville, North Carolina, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Cancer Center/fairview Hospital
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- Mount Carmel Health Center West
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Dec 2007
- Primary completion
- 23 Jul 2013
- Completion
- 13 Nov 2020
- Last update posted
- 3 Dec 2020
- Registered enrollment
- 52
- Registry id
- NCT00551070
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.